In rodent models of AD, Aβ1–42 drove NLRP3 activation and oxidative damage via the formation of TXNIP•Keap1 (Kelch-like ECH-associated protein-1)•NRF2 (nuclear factor erythroid 2-related factor 2) complexes. This evidence concerns the gene KEAP1 and Alzheimer disease.